ALN-4285

· Alnylam Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALN-4285, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate ALN-4285 in Adult Healthy Volunteers [Phase 1]